Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study
Crossref DOI link: https://doi.org/10.1007/s12325-020-01425-8
Published Online: 2020-07-09
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dalén, Johan
Luttropp, Karin
Svedbom, Axel
Black, Christopher M.
Kachroo, Sumesh http://orcid.org/0000-0002-7190-6323
Text and Data Mining valid from 2020-07-09
Version of Record valid from 2020-07-09
Article History
Received: 1 June 2020
First Online: 9 July 2020